Catalyst Wire Dossier Catalyst Wire Dossier

Oral Minoxidil (N1087)

minoxidil · Eurofarma Laboratorios S.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Oral Minoxidil (N1087), covering 2026-04-14 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia. [Phase 3]

See pricing